United States · FDA National Drug Code directory
Lanreotide Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-870_fd205110-15eb-4707-82b2-185e5bbf616b
- Product NDC
- 69097-870
- Form
- INJECTION
- Composition / generic term
- lanreotide acetate
- Labeler
- Cipla USA Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211224
- Source listing expiry
- 20261231
Source-listed ingredients
- LANREOTIDE ACETATE — 120 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE · 69097-870-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →